These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 9917908)

  • 1. Hypertrophic obstructive cardiomyopathy.
    Messmer BJ; Klues HG; Reith S; Schoendube FA; Hanrath P
    Adv Card Surg; 1998; 10():245-70. PubMed ID: 9917908
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of surgical septal myectomy and alcohol septal ablation with cardiac magnetic resonance imaging in patients with hypertrophic obstructive cardiomyopathy.
    Valeti US; Nishimura RA; Holmes DR; Araoz PA; Glockner JF; Breen JF; Ommen SR; Gersh BJ; Tajik AJ; Rihal CS; Schaff HV; Maron BJ
    J Am Coll Cardiol; 2007 Jan; 49(3):350-7. PubMed ID: 17239717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Septal myectomy for obstructive hypertrophic cardiomyopathy.
    Dearani JA; Danielson GK
    Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu; 2005; ():86-91. PubMed ID: 15818363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognosis of patients with hypertrophic obstructive cardiomyopathy after transaortic myectomy. Late results up to twenty-five years.
    Schulte HD; Bircks WH; Loesse B; Godehardt EA; Schwartzkopff B
    J Thorac Cardiovasc Surg; 1993 Oct; 106(4):709-17. PubMed ID: 8412267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extended myectomy for hypertrophic obstructive cardiomyopathy after failure or contraindication of septal ablation or with combined surgical procedures.
    Dörge H; Schmitto JD; Liakopoulos OJ; Walther S; Schöndube FA
    Thorac Cardiovasc Surg; 2004 Dec; 52(6):344-8. PubMed ID: 15573275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Recent advances in hypertrophic cardiomyopathy].
    Toshima H; Koga Y; Itaya M
    Kokyu To Junkan; 1984 Aug; 32(8):789-95. PubMed ID: 6151223
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of arrhythmia in hypertrophic cardiomyopathy].
    Lengfelder W; Senges J
    Dtsch Med Wochenschr; 1991 Sep; 116(36):1359-61. PubMed ID: 1679389
    [No Abstract]   [Full Text] [Related]  

  • 8. [Beta-adrenergic blockers and calcium antagonists in hypertrophic cardiomyopathy].
    Korovina EP
    Klin Med (Mosk); 1998; 76(12):30-5. PubMed ID: 10067289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medical and surgical therapy of hypertrophic cardiomyopathy.
    Bonow RO; Maron BJ; Leon MB; Cannon RO; Epstein SE
    Cardiovasc Clin; 1988; 19(1):221-39. PubMed ID: 2901911
    [No Abstract]   [Full Text] [Related]  

  • 10. Mechanisms for recurrent left ventricular outflow tract obstruction after septal myectomy for obstructive hypertrophic cardiomyopathy.
    Minakata K; Dearani JA; Schaff HV; O'Leary PW; Ommen SR; Danielson GK
    Ann Thorac Surg; 2005 Sep; 80(3):851-6. PubMed ID: 16122442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical correction of hypertrophic obstructive cardiomyopathy with combined myectomy, mobilisation and partial excision of the papillary muscles.
    Schoendube FA; Klues HG; Reith S; Messmer BJ
    Eur J Cardiothorac Surg; 1994; 8(11):603-8. PubMed ID: 7893501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcoronary ablation of septal hypertrophy compared with surgery in the treatment of hypertrophic obstructive cardiomyopathy.
    Jiang TY; Wu XS; Lu Q; Meng X; Jia CQ; Zhang Y
    Chin Med J (Engl); 2004 Feb; 117(2):296-8. PubMed ID: 14975219
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of obstructive hypertrophic cardiomyopathy symptoms and gradient resistant to first-line therapy with β-blockade or verapamil.
    Sherrid MV; Shetty A; Winson G; Kim B; Musat D; Alviar CL; Homel P; Balaram SK; Swistel DG
    Circ Heart Fail; 2013 Jul; 6(4):694-702. PubMed ID: 23704138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hypertrophic cardiomyopathy: which therapy? Comparison between beta blockers and calcium antagonists on the symptomatology and natural history of the disease].
    Schiavoni G; Favuzzi A; Manzoli U
    Cardiologia; 1985 Apr; 30(4):265-9. PubMed ID: 2870803
    [No Abstract]   [Full Text] [Related]  

  • 15. [Maintenance therapy and various tests during follow-up of cardiomyopathies].
    Ogasawara S; Kimata S
    Nihon Naika Gakkai Zasshi; 1993 Feb; 82(2):231-4. PubMed ID: 8098350
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical and echocardiographic determinants of long-term survival after surgical myectomy in obstructive hypertrophic cardiomyopathy.
    Woo A; Williams WG; Choi R; Wigle ED; Rozenblyum E; Fedwick K; Siu S; Ralph-Edwards A; Rakowski H
    Circulation; 2005 Apr; 111(16):2033-41. PubMed ID: 15824202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Aspects of treatment of hypertrophic obstructive cardiomyopathy with emphasis on the role of percutaneous transluminal ablation of the myocardial septum].
    Veselka J
    Vnitr Lek; 2001 Dec; 47(12):887-91. PubMed ID: 11826555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Surgical treatment of idiopathic hypertrophic subvalvular stenosis].
    Knyshov GV; Sitar LL; Ishenin IuM
    Grudn Khir; 1981; (4):13-9. PubMed ID: 7196364
    [No Abstract]   [Full Text] [Related]  

  • 19. Cardiac transplantation for hypertrophic cardiomyopathy: a valid therapeutic option.
    Coutu M; Perrault LP; White M; Pelletier GB; Racine N; Poirier NC; Carrier M
    J Heart Lung Transplant; 2004 Apr; 23(4):413-7. PubMed ID: 15063400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Idiopathic hypertrophic subvalvular stenosis: surgical treatment. Review of 10 cases].
    Castells E; Laforga R; Martínez F; Murtra M; Octavio de Toledo C; Puig Massana M
    Rev Esp Cardiol; 1973; 26(3):211-24. PubMed ID: 4146605
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.